Synthesis and evaluation of a novel urea-based 68 Ga-complex for imaging PSMA binding in tumor
Authors:
- 1 April 2018
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 59, 36-47
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Prostate-specific membrane antigen-based imagingUrologic Oncology: Seminars and Original Investigations, 2013
- 68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET ImagingBioconjugate Chemistry, 2012
- 2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate CancerClinical Cancer Research, 2011
- Prostate-Specific Membrane Antigen-Based TherapeuticsAdvances in Urology, 2011
- A Remote Arene-Binding Site on Prostate Specific Membrane Antigen Revealed by Antibody-Recruiting Small MoleculesJournal of the American Chemical Society, 2010
- 89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In VivoJournal of Nuclear Medicine, 2010
- 2-[18F]Fluoro-2-Deoxyglucose Positron Emission Tomography for the Detection of Disease in Patients with Prostate-Specific Antigen Relapse after Radical ProstatectomyClinical Cancer Research, 2005
- Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancerJournal of Cellular Biochemistry, 2003
- 11C-MCG: Synthesis, Uptake Selectivity, and Primate PET of a Probe for Glutamate Carboxypeptidase II (NAALADase)Molecular Imaging, 2002
- In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigenProstate Cancer and Prostatic Diseases, 2002